Rowasa

Rowasa is a brand name of mesalamine, approved by the FDA in the following formulation(s):

ROWASA (mesalamine - enema; rectal)

• 
  Manufacturer: MEDA PHARMS
  
  Approval date: December 24, 1987
  
  Strength(s): 4GM/60ML ^[RLD][AB]

Has a generic version of Rowasa been approved?

Yes. The following products are equivalent to Rowasa:

mesalamine enema; rectal

• 
  Manufacturer: PERRIGO ISRAEL
  
  Approval date: September 17, 2004
  
  Strength(s): 4GM/60ML ^[AB]


• 
  Manufacturer: TEVA
  
  Approval date: September 30, 2004
  
  Strength(s): 4GM/60ML ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Rowasa. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Rowasa.

See also...

• Rowasa Enema Consumer Information (Wolters Kluwer)
• Rowasa rectal Consumer Information (Cerner Multum)
• Rowasa Advanced Consumer Information (Micromedex)
• Mesalamine Controlled-Release Capsules Consumer Information (Wolters Kluwer)
• Mesalamine Delayed-Release Tablets Consumer Information (Wolters Kluwer)
• Mesalamine Enema Consumer Information (Wolters Kluwer)
• Mesalamine Extended-Release Capsules Consumer Information (Wolters Kluwer)
• Mesalamine Suppositories Consumer Information (Wolters Kluwer)
• Mesalamine Consumer Information (Cerner Multum)
• Mesalamine rectal Consumer Information (Cerner Multum)
• Mesalamine Advanced Consumer Information (Micromedex)
• Mesalamine Rectal Advanced Consumer Information (Micromedex)
• SfRowasa Advanced Consumer Information (Micromedex)
• Mesalamine AHFS DI Monographs (ASHP)